occurs in has participant quality has disease treated with drug INTERFERON ALFA-2A MEGESTROL NITROFURANTOIN OMEPRAZOLE TOLMETIN RABEPRAZOLE ALOSETRON PANTOPRAZOLE MIGLUSTAT TINIDAZOLE duodenum cancer acute cystitis diarrhea peptic esophagitis hepatitis C Gaucher's disease bacterial vaginosis rheumatoid arthritis gastroesophageal reflux disease anorexia nervosa Child Adult flatulence AE 10016766 CTCAE: E10697 SIDER: C0016204 NCIt: C37954 Flatulence is the production of a mixture of gases in the digestive tract of mammals or other animals that are byproducts of the digestion process. Such a mixture of gases is known as flatus, and is expelled from the rectum in a process colloquially referred to as "passing gas" or "farting". HPO: HP_0011024 YH a movement disorder AE that has an outcome of flatulence According to the Vaccine Adverse Event Reporting System (VAERS), 'flatulence' was mentioned in 102 VAERS reports (<0.1%) during1991-2001 (Reference: PMID: 12825543). movement disorder AE AE severity G1 AE severity G2